Functional Role of IL-22 in Psoriatic Arthritis

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2012 Mar 16

PMID 22417743

Citations 41

Authors

Anupam Mitra

Smriti K Raychaudhuri

Siba P Raychaudhuri

Affiliations

Soon will be listed here.

Abstract

Introduction: Interleukin-22 (IL-22) is a cytokine of IL-10 family with significant proliferative effect on different cell lines. Immunopathological role of IL-22 has been studied in rheumatoid arthritis (RA) and psoriasis. Here we are reporting the functional role of IL-22 in the inflammatory and proliferative cascades of psoriatic arthritis (PsA).

Method: From peripheral blood and synovial fluid (SF) of PsA (n = 15), RA (n = 15) and osteoarthritis (OA, n = 15) patients, mononuclear cells were obtained and magnetically sorted for CD3+ T cells. Fibroblast like synoviocytes (FLS) were isolated from the synovial tissue of PsA (n = 5), RA (n = 5) and OA (n = 5) patients. IL-22 levels in SF and serum were measured by enzyme linked immunosorbent assay (ELISA). Proliferative effect of human recombinant IL-22 (rIL-22) on FLS was assessed by MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, a yellow tetrazole) and CFSE dilution (Carboxyfluorescein succinimidyl ester) assays. Expression of IL-22Rα1 in FLS was determined by western blot.

Results: IL-22 levels were significantly elevated in SF of PsA patients (17.75 ± 3.46 pg/ml) compared to SF of OA (5.03 ± 0.39 pg/ml), p < 0.001. In MTT and CFSE dilution assays, rIL-22 (MTT, OD: 1.27 ± 0.06) induced significant proliferation of FLS derived from PsA patients compared to media (OD: 0.53 ± 0.02), p < 0.001. In addition, rIL-22 induced significantly more proliferation of FLS in presence of TNF-α. IL-22Rα1 was expressed in FLS of PsA, RA and OA patients. Anti IL-22R antibody significantly inhibited the proliferative effect of rIL-22. Further we demonstrated that activated synovial T cells of PsA and RA patients produced significantly more IL-22 than those of OA patients.

Conclusion: SF of PsA patients have higher concentration of IL-22 and rIL-22 induced marked proliferation of PsA derived FLS. Moreover combination of rIL-22 and TNF-α showed significantly more proliferative effect on FLS. IL-22Rα1 was expressed in FLS. Successful inhibition of IL-22 induced FLS proliferation by anti IL-22R antibody suggests that blocking of IL-22/IL-22R interaction may be considered as a novel therapeutic target for PsA.

Citing Articles

Alloferon and IL-22 receptor expression regulation on the pathogenesis of imiquimod-induced psoriasis.

Agura T, Jo H, Shin S, Jang Y, Choi C, Gwak I Sci Rep. 2025; 15(1):6671.

PMID: 39994364 PMC: 11850768. DOI: 10.1038/s41598-025-90961-w.

Inflammation and Neurodegeneration in Glaucoma: Isolated Eye Disease or a Part of a Systemic Disorder? - Serum Proteomic Analysis.

Okruszko M, Szablowski M, Zarzecki M, Michnowska-Kobylinska M, Lisowski L, Lapinska M J Inflamm Res. 2024; 17:1021-1037.

PMID: 38370463 PMC: 10874189. DOI: 10.2147/JIR.S434989.

The Role of Sclerostin in Rheumatic Diseases: A Review.

Jaskiewicz L, Chmielewski G, Kuna J, Stompor T, Krajewska-Wlodarczyk M J Clin Med. 2023; 12(19).

PMID: 37834893 PMC: 10573925. DOI: 10.3390/jcm12196248.

Psoriasis: A Primer for General Physicians.

Dasari S, Choudhary A, Madke B Cureus. 2023; 15(4):e38037.

PMID: 37228538 PMC: 10208009. DOI: 10.7759/cureus.38037.

Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.

Torosian K, Lal E, Kavanaugh A, Loomba R, Ajmera V, Guma M Semin Arthritis Rheum. 2023; 59:152165.

PMID: 36716599 PMC: 9992353. DOI: 10.1016/j.semarthrit.2023.152165.

References

Kotenko S, Langer J . Full house: 12 receptors for 27 cytokines. Int Immunopharmacol. 2004; 4(5):593-608. DOI: 10.1016/j.intimp.2004.01.003. View

Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld J . Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 2009; 60(2):390-5. DOI: 10.1002/art.24220. View

Renauld J . Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol. 2003; 3(8):667-76. DOI: 10.1038/nri1153. View

Zenewicz L, Flavell R . Recent advances in IL-22 biology. Int Immunol. 2011; 23(3):159-63. DOI: 10.1093/intimm/dxr001. View

Pestka S, Krause C, Sarkar D, Walter M, Shi Y, Fisher P . Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22:929-79. DOI: 10.1146/annurev.immunol.22.012703.104622. View

Ren J, Feng Z, Lv Z, Chen X, Li J . Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-α. J Rheumatol. 2011; 38(10):2112-8. DOI: 10.3899/jrheum.101377. View

Ritchlin C . Therapeutic considerations in spondyloarthritis patients who fail tumour necrosis factor antagonists. Best Pract Res Clin Rheumatol. 2010; 24(5):683-92. DOI: 10.1016/j.berh.2010.06.002. View

Choy E, Panayi G . Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001; 344(12):907-16. DOI: 10.1056/NEJM200103223441207. View

Gitter B, Labus J, Lees S, Scheetz M . Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology. 1989; 66(2):196-200. PMC: 1385086. View

10.

Gladman D . Psoriatic arthritis. Dermatol Ther. 2004; 17(5):350-63. DOI: 10.1111/j.1396-0296.2004.04038.x. View

11.

Kim K, Kim H, Park J, Park J, Oh H, Woo Y . Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum. 2011; 64(4):1015-23. DOI: 10.1002/art.33446. View

12.

Meephansan J, Ruchusatsawat K, Sindhupak W, Thorner P, Wongpiyabovorn J . Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. Eur J Dermatol. 2011; 21(4):501-4. DOI: 10.1684/ejd.2011.1335. View

13.

Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C . IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol. 2011; 41(7):1894-901. DOI: 10.1002/eji.201041197. View

14.

Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K . Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005; 52(4):1037-46. DOI: 10.1002/art.20965. View

15.

Fitch E, Harper E, Skorcheva I, Kurtz S, Blauvelt A . Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep. 2008; 9(6):461-7. PMC: 2893221. DOI: 10.1007/s11926-007-0075-1. View

16.

Dumoutier L, Louahed J, Renauld J . Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol. 2000; 164(4):1814-9. DOI: 10.4049/jimmunol.164.4.1814. View

17.

Dumoutier L, Van Roost E, Colau D, Renauld J . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A. 2000; 97(18):10144-9. PMC: 27764. DOI: 10.1073/pnas.170291697. View

18.

Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V . Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol. 2010; 184(9):5263-5270. DOI: 10.4049/jimmunol.0902464. View

19.

Fiocco U, Sfriso P, Oliviero F, Roux-Lombard P, Scagliori E, Cozzi L . Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther. 2010; 12(4):R148. PMC: 2945042. DOI: 10.1186/ar3090. View

20.

Mease P . TNFalpha therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis. 2004; 63(7):755-8. PMC: 1755077. DOI: 10.1136/ard.2004.020719. View